This mechanism contributes to increased thrombosis in COVID-19, in addition to the higher concentration of IL-1 and TNF-α produced by CRS, which leads to the suppressed activity of physiological anticoagulants (Figure 10) [75,77]. Here, TNF is linked to COVID-19.